Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Avenue Therapeutics, Inc. | StockGist | StockGist

Companies
ATXI
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ATXISCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Avenue Therapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001644963

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

3,183,426

Reporting Person

AVENUE THERAPEUTICS, INC.

Person Type

IA

CUSIP: 05360L403

Amendment History

3 filings

SCHEDULE 13G
Original
Feb 14, 20250000950170-25-020873
SCHEDULE 13G/A
Amendment 1
Feb 14, 20250001172661-25-001238
SCHEDULE 13G/A
Amendment 2
Latest
Viewing
Feb 17, 20260001193125-26-055056

Key Facts

Shares Owned

3,183,426

Recent Filings

Avenue Therapeutics, Inc.4 days ago

Avenue Therapeutics, Inc.1 months ago

Avenue Therapeutics, Inc.2 months ago

Avenue Therapeutics, Inc.3 months ago

Avenue Therapeutics, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice